Engineering immune-evasive allogeneic cellular immunotherapies

KE Martin, Q Hammer, K Perica, M Sadelain… - Nature Reviews …, 2024 - nature.com
Allogeneic cellular immunotherapies hold a great promise for cancer treatment owing to
their potential cost-effectiveness, scalability and on-demand availability. However, immune …

CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells

T Bexte, N Albinger, A Al Ajami, P Wendel… - Nature …, 2024 - nature.com
Chimeric antigen receptor (CAR)-modified natural killer (NK) cells show antileukemic activity
against acute myeloid leukemia (AML) in vivo. However, NK cell-mediated tumor killing is …

Deletion of the TMEM30A gene enables leukemic cell evasion of NK cell cytotoxicity

L Kristenson, C Badami, A Ljungberg… - Proceedings of the …, 2024 - National Acad Sciences
Natural killer (NK) cell immunotherapy has gained attention as a promising strategy for
treatment of various malignancies. In this study, we used a genome-wide CRISPR screen to …

Functional genomics identifies N-acetyllactosamine extension of complex N-glycans as a mechanism to evade lysis by natural killer cells

X Zhuang, J Woods, Y Ji, S Scheich, F Mo… - Cell reports, 2024 - cell.com
Natural killer (NK) cells are primary defenders against cancer precursors, but cancer cells
can persist by evading immune surveillance. To investigate the genetic mechanisms …

Hypersialylation and multiple myeloma

M O'Dwyer, S Glavey, R McAvera, A Natoni… - Frontiers in …, 2024 - frontiersin.org
There is growing recognition of the importance of sialylation as a critical post translational
modification in cancer. In this article we review the role of increased cell surface sialylation …

[HTML][HTML] Proteolytic cleavage of Golgi glycosyltransferases by SPPL3 and other proteases and its implications for cellular glycosylation

M Voss - Biochimica et Biophysica Acta (BBA)-General Subjects, 2024 - Elsevier
Glycosylation of proteins and lipids is of fundamental importance in multicellular eukaryotes.
The vast diversity of glycan structures observed is generated in the Golgi apparatus by the …

[HTML][HTML] Strategies to disrupt NKG2A: HLA-E interactions for improved anti-cancer immunity

JG Fisher, LV Graham, MD Blunt - Oncotarget, 2024 - ncbi.nlm.nih.gov
The inhibitory receptor NKG2A, which forms a heterodimer with CD94, is expressed by~
50% of peripheral blood NK cells and is further upregulated following NK cell expansion ex …

The G Protein–Coupled Receptor GPR56 Is an Inhibitory Checkpoint for NK Cell Migration

D Palacios, RK Majhi, EK Szabo, D Clement… - The Journal of …, 2024 - journals.aai.org
G protein–coupled receptors (GPCRs) represent the largest family of surface receptors and
are responsible for key physiological functions, including cell growth, neurotransmission …

[HTML][HTML] IFNγ mediates the resistance of tumor cells to distinct NK cell subsets

T Hofman, SW Ng, I Garcés-Lázaro… - … for Immunotherapy of …, 2024 - ncbi.nlm.nih.gov
Background Immune checkpoint blockade targeting the adaptive immune system has
revolutionized the treatment of cancer. Despite impressive clinical benefits observed, patient …

Highlight of 2023: Unlocking the therapeutic potential of natural killer cells-advances in adaptive functions, cellular engineering and immunotherapy.

PY Lam… - Immunology and Cell …, 2024 - europepmc.org
Natural killer (NK) cells possess potent cytotoxicity against infected and cancerous cells and
hold promise in the development of new immunotherapies. This article for the Highlights of …